Vascular targets of redox signalling in diabetes mellitus

Diabetologia

Volumn 45, Issue 4, 2002, Pages 476-494

  Spitaler, M M ^a   Graier, Wolfgang F ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

AP 1; Ca2+ homeostasis; Diabetes; Matrix metalloproteinases; NF B; NFAT; Nitric oxide; Rac; Reactive oxygen species; RhoA; Serine threonine kinases; Superoxide; Tyrosine kinases

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; METALLOPROTEINASE; PROTEIN KINASE; REACTIVE OXYGEN METABOLITE;

CALCIUM HOMEOSTASIS; CYTOSKELETON; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION; VASCULAR DISEASE; ANIMAL; BLOOD; BLOOD VESSEL; DIABETIC ANGIOPATHY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMAL; BLOOD VESSELS; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; HUMAN; MAP KINASE SIGNALING SYSTEM; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; VASCULAR DISEASES; ANIMALS; HUMANS;

EID: 0035988181     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-002-0782-0     Document Type: Review

References (222)

1. Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction
2. Protein kinase C activation: Isozyme-specific effects on metabolism and cardiovascular complications in diabetes
3. The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease
4. Diabetes mellitus enhances vascular matrix metalloproteinase activity: Role of oxidative stress
5. Primary endothelial dysfunction: Atherosclerosis
6. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase
7. Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae
8. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress
9. NAD(P)H oxidase: Role in cardiovascular biology and disease
10. Mechanisms underlying endothelial dysfunction in diabetes mellitus
11. Increased superoxide anion formation in endothelial cells during hyperglycemia: An adaptive response or initial step of vascular dysfunction?
12. Reactive oxygen species: Associated pathology
13. Reactive Oxygen species as mediators of signal transduction in cardiovascular disease
14. Ras, superoxide and signal transduction
15. Nitric oxide inhibition of lipid peroxidation: Kinetics of reaction with lipid peroxyl radicals and comparison with alpha-tocopherol
16. Nitric oxide and peroxynitrite. The ugly, the uglier and the not so good: A personal view of recent controversies
17. Oxidative stress as a regulator of gene expression in the vasculature
18. Myeloperoxidase: A key regulator of neutrophile oxiddant production
19. Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose
20. Glucose oxidation and low-density lipoprotein-induced macrophage ceroid accumulation: Possible implications for diabetic atherosclerosis
21. Transition metals bind to glycated proteins forming redox active "glycochelates": Implications for the pathogenesis of certain diabetic complications
22. Glycochelates and the etiology of diabetic peripheral neuropathy
23. Small G proteins and the neutrophil NADPH oxidase
24. Assembly and regulation of NADPH oxidase and nitric oxide synthase
25. Assembly of the phagocyte NADPH oxidase: Molecular interaction of oxidase proteins
26. Novel insight into current models of NADPH oxidase regulation, assembly and localization in human polymorphonuclear leukocytes
27. Glucose-enriched medium enhances cell-mediated low density lipoprotein peroxidation
28. 2+/EDRF signaling are due to generation of superoxide anions
29. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells
30. Angiotensin II stimulates NADH and NADPH activity in cultured vascular smooth muscle cells
31. Sites of superoxide anion production detected by lucigenin in calf pulmonary artery smooth muscle
32. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium
33. An NADPH oxidase superoxide generating system in the rabbit aorta
34. Vascular superoxide production by NAD(P)H oxidase: Association with endothelial dysfunction and clinical risk factors
35. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor
36. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKCbeta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes
37. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and In vivo: A specific vascular action of insulin
38. Induction of endothelin-1 expression by glucose: An effect of protein kinase C activation
39. Identification of intracellular sites of superoxide production in stimulated neutrophils
40. On the mechanism of prostacyclin and thromboxane A2 biosynthesis
41. Selective impairment of endothelium-dependent relaxations by prostaglandin endoperoxide
42. Acute and chronic effects of thromboxane A2 inhibition on the renal hemodynamicsin streptozotocin-induced diabetic rats
43. Effect of camonagrel, a selective thromboxane synthase inhibitor, on retinal vascularization in experimental diabetes
44. Effect of DT-TX 30, a combined thromboxane synthase inhibitor and thromboxane receptor antagonist, on retinal vascularity in experimental diabetes mellitus
45. Prostaglandins and diabetic nephropathy
46. 2 as an endothelium-derived contracting factor in diabetic state
47. Contraction of diabetic rabbit aorta caused by endothelium-derived PGH2-TXA2
48. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta
49. 2-efflux which injures endothelial cells by an extracellular mechanism
50. Protection of perfused lung from oxidant injury by inhibitors of anion exchange
51. Dysfunction of vascular endothelium in diabetes mellitus
52. Free radicals mediate endothelial cell dysfunction caused by elevated glucose
53. Review of alterations in endothelial nitric oxide production in diabetes: Protective role of arginine on endothelial dysfunction
54. 2+/cGMP response by scavanging superoxide anions
55. Free radicals mediate endothelial dysfunction of coronary arterioles in diabetes
56. Diabetic-induced endothelial dysfunction in rat aorta: Role of hydroxyl radicals
57. High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress
58. Time course study of oxidative stress in aorta and heart of diabetic rat
59. Relationship among cholesterol, superoxide anion and endothelium-dependent relaxation in diabetic rats
60. Changes in superoxide dismutase mRNA expression by streptozotocin-induced diabetes
61. Gene transfer of superoxide dismutase isoforms reverses endothelial dysfunction in diabetic rabbit aorta
62. Impairment of endothelial nitric oxide production by acute glucose overload
63. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide
64. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells
65. Mechanism of impaired nitric oxide synthase activity in skeletal muscle of streptozotocin-induced diabetic rats
66. Influence of diabetes on cardiac nitric oxide synthase expression and activity
67. Endothelial nitric oxide synthase (eNOS) expression and localization in healthy and diabetic rat hearts
68. Impaired arginine metabolism and NO synthesis in coronary endothelial cells of the spontaneously diabetic BB rat
69. Reversal by L-arginine of a dysfunctional arginine/nitric oxide pathway in the endothelium of the genetic diabetic BB rat
70. Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin
71. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site
72. Impaired nitric oxide production in coronary endothelial cells of the spontaneously diabetic BB rat is due to tetrahydrobiopterin deficiency
73. Generation of superoxide by purified brain nitric oxide synthase
74. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors
75. 2+/calmodulin-dependent and tetrahydrobiopterin regulatory process
76. Endothelial regulation of vasomotion in apoE-deficient mice: Implications for interactions between peroxynitrite and tetrahydrobiopterin
77. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus
78. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
79. The missing link: A single inifying mechanism for diabetic complication
80. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels
81. Impairment of endothelium dependent relaxation in the diabetic rat heart: Mechanisms and implications
82. Effect of chronic insulin treatment on NO production and endothelium-dependent relaxation in aortae from established STZ-induced diabetic rats
83. Loss of endothelial pertussis toxin-sensitive G protein function in atherosclerotic porcine coronary arteries
84. Hyperglycemic pseudohypoxia and diabetic complications
85. Aldose reductase and myo-inositol in endothelial cell dysfunction caused by elevated glucose
86. Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta
87. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation
88. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium
89. Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium
90. Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells
91. Rho GTPases and the actin cytoskeleton
92. Increasing complexity of the Ras signaling pathway
93. The RhoA-dependent assembly of focal adhesions in Swiss 3T3 cells is associated with increased tyrosine phosphorylation and the recruitment of both pp125FAK and protein kinase C-delta to focal adhesions
94. Rho, Rac and Cdc42 regulate actin organization and cell adhesion in macrophages
95. Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats
96. Regulation of reactive-oxygen-species generation in fibroblasts by Rac1
97. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts
98. Refined crystal structure of the triphosphate conformation of H-ras p21 at 1.35 A resolution: Implications for the mechanism of GTP hydrolysis
99. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone
100. All fas proteins are polyisoprenylated but only some are palmitoylated
101. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation
102. Targeting Rho in cardiovascular disease
103. Involvement of Rho GTPases in the transcriptional inhibition of preproendothelin-1 gene expression by simvastatin in vascular endothelial cells
104. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase
105. Superoxide-mediated actin response in post-hypoxic endothelial cells
106. The actin cytoskeleton reorganization induced by Rac1 requires the production of superoxide
107. Neuroprotection mediated by changes in the endothelial actin cytoskeleton
108. Oxidant signaling in vascular cell growth, death, and survival: A review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling
109. Hydrogen peroxide activates extracellular signal-regulated kinase via protein kinase C, Raf-1, and MEK1
110. Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury
111. Amelioration of hyperglycemic and hyperosmotic induced vascular dysfunction by in vivo inhibition of protein kinase C and p38 MAP kinase pathway in the rat mesenteric microcirculation
112. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase
113. Sounding the alarm: Protein kinase cascades activated by stress and inflammation
114. Mechanisms and consequences of activation of protein kinase B/Akt
115. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells
116. Reactive oxygen species activate p90 ribosomal S6 kinase via Fyn and Ras
117. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology
118. 2/CAKbeta represents a redox-sensitive tyrosine kinase in vascular smooth muscle cells
119. Reactive oxygen species activate focal adhesion kinase, paxillin and p130cas tyrosine phosphorylation in endothelial cells
120. Genistein prevents the glucose autoxidation mediated atherogenic modification of low density lipoprotein
121. Matrix metalloproteinases
122. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester
123. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines
124. Is NF-kappaB the sensor of oxidative stress?
125. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability
126. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
127. Matrix metalloproteinases and cardiovascular disease
128. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes
129. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient ice
130. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression
131. Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change
132. 2+ entry and nitric oxide synthase in bovine endothelial cells
133. 2+-ATPase
134. Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression
135. Calcium as a versatile second messenger in the control of gene expression
136. Calcium oscillations increase the efficiency and specificity of gene expression
137. i oscillation frequency regulates agonist-stimulated NF-kappaB transcriptional activity
138. Potassium channel function in vascular disease
139. 2+ regulation and endothelial vascular function
140. + is an endothelium-derived hyperpolarizing factor in rat arteries
141. Alterations in endothelium-dependent hyperpolarization and relaxation in mesenteric arteries from streptozotocin-induced diabetic rats
142. Comparison of effects of diabetes mellitus on an EDHF-dependent and an EDHF-independent artery
143. Responses of cerebral arterioles in diabetic rats to activation of ATP-sensitive potassium channels
144. + channel openers in cerebral arteries from diabetic rats
145. Xanthine oxidase inhibits transmembrane signal transduction in vascular endothelial cells
146. 2+ signaling pathways
147. 2+ oscillation in cultured endothelial cells from bovine aorta: A possible role of superoxide anion
148. 2+ influx into the endothelium contributes to the decrease in endothelium-dependent relaxation in the aorta of streptozotocin-induced diabetic mice
149. 2+ mobilization in the aortic endothelium in streptozotocin-induced diabetic and cholesterol-fed mice
150. i of cardiac myocytes
151. 2+ currents in ventricular myocytes from rats with chronic diabetes
152. Oxidant stress activates a non-selective cation channel responsible for membrane depolarization in calf vascular endothelial cells
153. Evidence for a role of Trp proteins in the oxidative stress-induced membrane conductances of porcine aortic endothelial cells
154. Oxygen-derived free radical stress activates nonselective cation current in guinea pig ventricular myocytes. Role of sulfhydryl groups
155. 2+ channel of intermediate conductance in bovine aortic endothelial cells
156. The small G-protein Rac mediates depolarization-induced superoxide formation in human endothelial cells
157. 2+ signaling in vascular endothelial cells
158. + channels in rat cerebral artery smooth muscle cells
159. Differential role of extra- and intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells
160. + channel contributes to bradykinin-induced stimulation of nitric oxide synthesis in pig aortic endothelial cells
161. 2+-ATPase of vascular smooth muscle sarcoplasmic reticulum by reactive oxygen intermediates
162. 2+ release from vascular smooth muscle sarcoplasmic reticulum
163. 2+ channel
164. 2+ release channel from skeletal muscle sarcoplasmic reticulum
165. Effects of hydroxyl radical and sulfhydryl reagents on the open probability of the purified cardiac ryanodine receptor channel incorporated into planar lipid bilayers
166. 2+ from mitochondria without inactivating the mitochondrial inner-membrane pore
167. 2+-dependent pore of possible relevance to re-perfusion-induced injury. Evidence that ADP facilitates pore interconversion between the closed and open states
168. + exchanger
169. 2+ signalling in diabetic patients is due to increased formation of superoxide anions and reduced nitric oxide production
170. Reduced responsiveness of hypercholesterolemic rabbit aortic smooth muscle cells to nitric oxide
171. Action of probucol in arteries from normal and hypercholesterolemic rabbits
172. 2+ influx is involved in the mechanism of enhanced proliferation of cultured vascular smooth muscle cells from spotaneously diabetic Goto-Kakizaki rats
173. Norepinephrine-mediated calcium signaling is altered in vascular smooth muscle of diabetic rat
174. 2+ distribution
175. Glucose-induced alterations of cytosolic free calcium in cultured rat tail artery vascular smooth muscle cells
176. Chronic treatment in vivo with dimethylthiourea, a hydroxyl radical scavenger, prevents diabetes-induced endothelial dysfunction
177. Hemostatic gene expression and vascular disease in obesity: Insights from studies of genetically obese mice
178. Generation of reactive oxygen intermediates, activation of NF-kappaB, and induction of apoptosis in human endothelial cells by glucose: Role of nitric oxide synthase?
179. Hyperinsulinemia enhances transcriptional activity of nuclear factor-kappaB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells
180. Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: Prevention by calphostin C
181. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: A link between surface-associated AGEs and diabetic complications
182. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes
183. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells
184. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion
185. Glycated serum albumin-induced nitric oxide production in vascular smooth muscle cells by nuclear factor kappaB-dependent transcriptional activation of inducible nitric oxide synthase
186. Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells
187. Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose
188. Diabetic endothelial dysfunction: The role of poly(ADP-ribose) polymerase activation
189. Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes
190. i oscillations in T lymphocytes
191. 2+ oscillations in pancreatic acinar cells: Spatiotemporal relationships and functional implications
192. 2+ oscillations in exocrine cells evoked by agonist and inositol trisphosphate
193. Exposure to elevated D-glucose concentrations modulates vascular endothelial cell vasodilatatory response
194. Role of superoxide anions in changes of endothelial vasoactive response during acute hyperglycemia
195. Stimulation of endothelin-1 production by thrombin, but lack of interference by high ambient glucose in vitro
196. Modulation by high glucose of adhesion molecule expression
197. High-glucose-triggered apoptosis in cultured endothelial cells
198. "Tell me where is calcium bred": Clarifying the roles of nuclear calcium
199. New insights into the control of map kinase pathways
200. Nuclear versus perinuclear and cytoplasmic calcium in osteoclasts
201. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
202. Nuclear factor of activated T cells contains Fos and Jun
203. Analysis of the preexisting and nuclear forms of nuclear factor of activated T cells
204. Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity
205. Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factorNFAT1 in stimulated immune cells
206. The cyclosporin A-sensitive nuclear factor of activated T cells (NFAT) proteins are expressed in vascular smooth muscle cells
207. 2+-dependent gene expression mediated by MEF2 transcription factors
208. Dynamic equilibrium between calcineurin and kinase activities regulates the phosphorylation state and localization of the nuclear factor of activated T-cells
209. Crosstalk between cellular morphology and calcium oscillation patterns. Insights from a stochastic computer model
210. Calcium influx triggers the sequential proteolysis of extracellular and cytoplasmic domains of E-cadherin, leading to loss of beta-catenin from cell-cell contacts
211. Cyclic changes in the organization of cell adhesions and the associated cytosceleton, induced by stimulation of tyrosine phosphorylation in bovine aortic endothelial cells
212. Nuclear-cytoplasmic shuttling of the focal contact protein, zyxin: A potential mechanism for communication between sites of cell adhesion and the nucleus
213. Calcium sparks in vascular smooth muscle: Relaxation regulators
214. Variability in spontaneous subcellular calcium release in guinea-pig ileum smooth muscle cells
215. Sarcoplasmic reticulum-sarcolemma interactions and vascular smooth muscle tone
216. 2+-dependent ion channels in single myocytes from rat portal vein
217. 2+ elevation beneath the cell membrane
218. Signal transduction via the MAP kinases: Proceed at your own RSK
219. Evidence for two catalytically active kinase domains in pp90rsk
220. The 90-kDa ribosomal S6 kinase (pp90rsk) phosphorylates the N-terminal regulatory domain of IkappaBalpha and stimulates its degradation in vitro
221. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase
222. Oxidative stress and gene regulation